trending Market Intelligence /marketintelligence/en/news-insights/trending/ratctxcj4mtjgb054qaq_a2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Liberty Health to acquire 75% of US cannabis license holder

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Liberty Health to acquire 75% of US cannabis license holder

Toronto's Liberty Health Sciences Inc. agreed to acquire 75% of Massachusetts-based William Noyes Webster Foundation Inc. for $16 million.

The foundation has an integrated medical cannabis license in the U.S. state, operating a dispensary and a cultivation and processing facility in Plymouth nearing completion.

Liberty Health said the transaction, which is expected to close in May, expands its footprint in the U.S. to Massachusetts. The acquisition remains subject to governmental approvals, and follows similar deals in the U.S.